In breast cancer, dysregulation of the PI3K/AKT/mTOR pathway occurs through several mechanisms, such as increased PI3K activity, loss of inhibitory functions, or mutations in tumor suppressor genes like INPP4B and PTEN. The gene discussed is PIK3CA; the disease is breast carcinoma.